摘要
双酚A (BPA)是一种工业上普遍存在的化合物,经常用于合成聚合物和环氧树脂。双酚a是公认的内分泌干扰物和异种雌激素化合物。流行病学和实验研究的证据表明,围产期暴露于BPA(妊娠和/或哺乳期)会增加各种疾病的风险,包括心血管系统。发育规划指的是在发育的关键窗口期,环境的破坏会影响身体系统的结构和生理,在后期造成永久性的变化。双酚a影响后代患非传染性疾病的发育程序。在这篇综述中,我们通过已发表的流行病学和实验证据,讨论了与围产期BPA暴露相关的心血管疾病的发展规划。大多数研究报告发现,围产期BPA暴露与胎儿、新生儿和成年期不良心血管反应呈正相关。可能的潜在机制包括心肌发育、自主张力、胶原和非胶原细胞外基质、心脏重塑和钙稳态以及线粒体能量代谢相关基因的表观遗传修饰。表观遗传学可以改变任何疾病的结果。因此,在这篇综述中,我们还讨论了表观遗传学在预防围产期BPA暴露后心血管疾病中的作用。我们还强调了未来与心血管介入相关的治疗和药物输送如何基于表观遗传标记。
关键词: 双酚A,毒性,心血管系统,发育程序,表观遗传学,双酚S。
Current Medicinal Chemistry
Title:Perinatal Exposure to Bisphenol A and Developmental Programming of the Cardiovascular Changes in the Offspring
Volume: 29 Issue: 24
关键词: 双酚A,毒性,心血管系统,发育程序,表观遗传学,双酚S。
摘要: Bisphenol A (BPA) is an industrial ubiquitous compound, frequently used to produce synthetic polymers and epoxy resins. BPA is a well-recognized endocrine disruptor and xenoestrogen compound. Evidence from epidemiological and experimental studies suggests that perinatal BPA exposure (gestation and/or lactation) increases the risk of developing various diseases, including the cardiovascular system. Developmental programming refers to environmental insults during the critical window of development that affect the structure and physiology of body systems, causing permanent changes in later stages. BPA influences the developmental programming of non-communicable diseases in the offspring. In the present review, we discuss the developmental programming of cardiovascular diseases related to perinatal exposure to BPA, supported by epidemiological and experimental evidence from published literature. The majority of the reported studies found a positive association between perinatal BPA exposure and adverse cardiovascular repercussions in the fetal, neonatal, and adulthood stages. The possible underlying mechanisms include epigenetic modifications of genes involved in cardiac muscle development, autonomic tone, collagenous and non-collagenous extracellular matrix, cardiac remodeling and calcium homeostasis, and mitochondrial energy metabolism. Epigenetics can modify the outcome of any disease. Hence, in the present review, we also discuss the role of epigenetics in preventing cardiovascular diseases following perinatal exposure to BPA. We also highlight how future treatment and drug delivery related to cardiovascular involvement could be based on epigenetic markers.
Export Options
About this article
Cite this article as:
Perinatal Exposure to Bisphenol A and Developmental Programming of the Cardiovascular Changes in the Offspring, Current Medicinal Chemistry 2022; 29 (24) . https://dx.doi.org/10.2174/0929867328666211206111835
DOI https://dx.doi.org/10.2174/0929867328666211206111835 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Male Fertility-Implications of Anticancer Treatment and Strategies to Mitigate Gonadotoxicity
Anti-Cancer Agents in Medicinal Chemistry Use of Non-steroidal Anti-inflammatory Drugs in Pregnancy: Impact on the Fetus and Newborn
Current Drug Metabolism Part-Time α-Secretases: The Functional Biology of ADAM 9, 10 and 17
Current Alzheimer Research Nitrogen Biobank for Cardiovascular Research
Current Cardiology Reviews bmp3 is Required for Integrity of Blood Brain Barrier by Promoting Pericyte Coverage in Zebrafish Embryos
Current Molecular Medicine Sex Differences in Biomarkers for Predicting Cardiovascular and Coronary Events
Current Vascular Pharmacology Experimental Developments and Review of Recent Patents for the Repair of Skeletal Muscles by Methods of Regenerative Medicine
Recent Patents on Regenerative Medicine Buccal Delivery of Methimazole as an Alternative Means for Improvement of Drug Bioavailability: Permeation Studies and Matrix System Design
Current Pharmaceutical Design Immunoproteasome in Cancer and Neuropathologies: A New Therapeutic Target?
Current Pharmaceutical Design Cardiovascular Toxicity from the Perspective of Oxidative Stress, Electron Transfer, and Prevention by Antioxidants
Current Vascular Pharmacology Targeting the Secretory Pathway for Anti-Inflammatory Drug Development
Current Topics in Medicinal Chemistry Prophylactic Neuroprotection
Current Drug Targets Subject Index to Volume 4
Current Genomics Medical Treatment of Uterine Arteriovenous Malformations: A Case Report
Current Women`s Health Reviews Role of Vitamins in Human Health and Nutrition: Sources and Morbidity
Current Nutrition & Food Science Targeting Microtubules to Inhibit Angiogenesis and Disrupt Tumour Vasculature:Implications for Cancer Treatment
Current Cancer Drug Targets N6-methyladenine RNA Modification (m<sup>6</sup>A): An Emerging Regulator of Metabolic Diseases
Current Drug Targets Tumor Growth-Promoting Properties of Macrophage Migration Inhibitory Factor
Current Pharmaceutical Design Molecular Imaging to Monitor Repair of Myocardial Infarction Using Genetically Engineered Bone Marrow-Derived Mesenchymal Stem Cells
Current Gene Therapy Cardiac Workup of Ischemic Stroke
Current Cardiology Reviews